Patents Assigned to Duquesne University of the Holy Spririt
  • In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts
    Patent number: 8679511
    Abstract: An in-situ gel ophthalmic drug delivery system for estrogen containing an estrogen, a solubilizing and complexing agent, a humectant, a sorbic acid or sorbic acid based stabilizer, an optional chelating agent and gellan gum in the amount of about 0.1-0.5% w/v, optionally 0.1-0.3% w/v, of the composition.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: March 25, 2014
    Assignee: Duquesne University of the Holy Spririt
    Inventors: Moji Christianah Adeyeye, Vicki L. Davis, Uday K. Kotreka